Northern Trust
MGCD

Northern Trust’s MGC Diagnostics Corporation MGCD Stock Holding History

Northern Trust’s Portfolio MGCD Stock Details MGCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,470
Closed -$126K – 4341
2017
Q4 		$126K Buy
11,470
+1,285
+13% +$12.4K ﹤0.01% 3931
2017
Q3 		$91K Buy
+10,185
New +$82.7K ﹤0.01% 3975

Northern Trust's MGCD Position: Q1 2018 in Review

Northern Trust sold out of MGC Diagnostics Corporation (MGCD) in Q1 2018, closing a stake of 11,470 shares — an estimated $126K sold.

Northern Trust first reported a position in MGCD in Q3 2017 and held it in 2 quarters. The position peaked at $126K in Q4 2017. 0 funds tracked by Wall St. Rank hold MGCD as of Q1 2018.

  • Northern Trust reported no remaining MGC Diagnostics Corporation position as of Q1 2018 after selling out during the quarter.
  • Northern Trust sold 11,470 MGC Diagnostics Corporation shares in Q1 2018, an estimated $126K.
  • Northern Trust first reported a position in MGC Diagnostics Corporation in Q3 2017 and held it in 2 quarters.
  • Northern Trust's MGC Diagnostics Corporation position peaked at $126K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q1 2018.

Based on Northern Trust's 13F filing for Q1 2018, filed 9 May 2018.